Edesa Biotech (EDSA) Interest Coverage Ratio (2014 - 2026)
Edesa Biotech (EDSA) posted Interest Coverage Ratio of 23.14 for Q4 2025, down 22.99% sequentially from 18.82 in Q2 2025, and down 23.32% YoY from 30.18 in Q4 2024.
Edesa Biotech (EDSA) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Edesa Biotech has reported Interest Coverage Ratio for 12 years, with the latest figure at 23.14 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 23.32% year-over-year to 23.14 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 82.57 (down 18.4% YoY) and the FY2025 annual result came in at 5.38, down 1285.01% from the prior year.
- Interest Coverage Ratio slipped to 23.14 in Q4 2025 per EDSA's latest filing, from 18.82 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.19 in Q3 2022 and troughed at 51.02 in Q4 2021.
- A 5-year average of 11.61 and a median of 3.09 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2023: Interest Coverage Ratio soared 97.61% in 2021, then tumbled 15817.05% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 51.02 in 2021, then surged by 97.37% to 1.34 in 2022, then increased by 17.18% to 1.11 in 2023, then sank by 1591.52% to 18.77 in 2024, then fell by 23.32% to 23.14 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 23.14, 18.82, and 16.2 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.84 |
| Dec 31, 2025 | -23.14 |
| Jun 30, 2025 | -18.82 |
| Mar 31, 2025 | -16.20 |
| Dec 31, 2024 | -18.77 |
| Sep 30, 2024 | -12.88 |
| Jun 30, 2024 | -19.10 |
| Mar 31, 2024 | -1.33 |
| Dec 31, 2023 | -1.11 |
| Sep 30, 2023 | -29.91 |
| Jun 30, 2023 | -16.85 |
| Mar 31, 2023 | -1.36 |
| Dec 31, 2022 | -1.34 |
| Sep 30, 2022 | -0.19 |
| Jun 30, 2022 | -3.09 |
| Mar 31, 2022 | -1.00 |
| Dec 31, 2021 | -51.02 |
| Sep 30, 2021 | -0.47 |
| Jun 30, 2021 | -3.07 |
| Mar 31, 2021 | -1.00 |